Clinical Trial Update: Botswana Tenofovir Oral HIV Prophylaxis Trial [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating oral tenofovir for HIV pre-exposure prophylaxis in Botswana has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Viread (Tenofovir disoproxil fumarate) (Tenofovir disoproxil fumarate)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: HIV Infection | Phase 2, Phase 3 | Status: TERMINATED